×
About 3,165 results

ALLMedicine™ Valvular Heart Disease Center

Research & Reviews  1,002 results

Hypomagnesaemia causing functional hypoparathyroidism in rheumatic mitral stenosis lead...
https://doi.org/10.1136/bcr-2021-244176
BMJ Case Reports; Jacob J, Raghothama S et. al.

Jul 20th, 2021 - A 23-year-old young woman with a known history of valvular heart disease of rheumatic origin, post balloon mitral valvotomy 5 years ago, presented with fever, palpitations and breathlessness. ECG showed atrial fibrillation with fast ventricular ra...

Advanced cardiovascular multimodal imaging and aortic stenosis.
https://doi.org/10.1007/s10741-021-10131-8 10.1016/j.jcmg.2017.09.019 10.1016/0735-1097(93)90249-Z 10.1016/j.jcmg.2018.10.034 10.1155/2012/145202 10.1016/j.echo.2017.02.009 10.1136/hrt.2009.177345 10.1161/CIRCIMAGING.114.002041 10.1111/echo.12051 10.1136/heartjnl-2018-313003 10.1186/1532-429X-13-25 10.1081/JCMR-200065639 10.1016/j.mri.2014.04.017 10.1253/circj.CJ-11-0568 10.1161/01.CIR.94.12.3318 10.1016/j.jcmg.2019.03.029 10.1161/CIRCULATIONAHA.117.032839 10.1016/j.jcmg.2018.11.026 10.1016/j.jcmg.2017.09.005 10.1016/j.jcmg.2015.11.005 10.1016/j.mri.2016.05.008 10.1016/j.jacc.2017.12.035 10.2214/AJR.09.3164 10.1161/01.CIR.0000135469.82545.D0 10.1136/heart.84.6.670 10.1016/j.jacc.2013.07.040 10.1259/bjr.20190688 10.1161/01.CIR.0000155623.48408.C5 10.1016/S0735-1097(03)00707-1 10.1016/j.jacc.2008.11.056 10.1161/01.CIR.90.2.844 10.1136/heart.88.4.348 10.1016/S0003-4975(98)00075-7 10.1161/01.RES.59.3.310 10.1111/j.1476-5381.2010.01084.x 10.1016/j.ejphar.2008.05.051 10.1016/j.carpath.2005.01.002 10.1016/S0735-1097(01)01705-3 10.1161/01.CIR.0000035655.45453.D2 10.1093/eurheartj/ehi706 10.1111/joim.12335 10.1016/j.cjca.2014.03.025 10.1007/s11739-011-0592-9 10.1586/14779072.2015.1037284 10.2353/ajpath.2007.070251 10.1016/j.numecd.2015.02.001 10.1161/CIRCGENETICS.108.820795 10.1136/heart.85.6.635 10.1111/j.1540-8175.2010.01256.x 10.1161/CIRCULATIONAHA.106.668681 10.1016/j.jacc.2011.08.072 10.1161/CIRCIMAGING.111.967554 10.1136/hrt.2004.044099 10.1093/oxfordjournals.eurheartj.a015209 10.5543/tkda.2017.43037 10.1093/ehjci/jes115 10.1161/CIRCIMAGING.112.977348 10.1016/j.jjcc.2013.05.001 10.1111/j.1540-8175.2012.01783.x 10.1016/j.jcmg.2014.12.009 10.1111/echo.12555 10.1093/ejechocard/jep224 10.11152/mu-1456 10.1016/j.athoracsur.2013.05.018 10.1186/s43044-019-0037-8 10.1186/1532-429X-14-7 10.1186/s12968-020-00633-z 10.1136/hrt.2003.022376 10.1016/j.ejrad.2006.02.011 10.1016/j.acvd.2016.04.006 10.1161/01.CIR.87.4.1239 10.1161/01.CIR.0000095268.47282.A1 10.1118/1.595736 10.1002/mrm.1910320308 10.1016/j.amjcard.2010.03.019 10.1016/j.jjcc.2014.07.015 10.1002/jmri.25305 10.1007/s00247-014-3246-z 10.1038/s41598-020-66659-6 10.1007/s10554-016-0938-5 10.1002/mrm.26387 10.1136/openhrt-2019-001158 10.1002/jmri.26847 10.1002/jmri.22519 10.1007/s10237-010-0238-2 10.1002/mrm.26687 10.1161/CIRCIMAGING.113.000528 10.1016/j.pcad.2006.11.001 10.1152/ajpheart.00017.2018 10.1161/01.CIR.79.4.744 10.1253/circj.cj-11-0568 10.1016/j.jcmg.2019.06.014 10.1093/ehjci/jez201 10.1186/s12968-020-00632-0 10.4070/kcj.2014.44.5.312 10.1016/j.jcmg.2016.10.007 10.1016/j.ihj.2017.05.027 10.1093/eurheartj/ehx353 10.1016/j.jcmg.2018.05.028 10.1038/s41598-019-51930-2 10.1016/j.jacc.2010.11.013 10.1093/ehjci/jeu182 10.1007/s00330-006-0244-z 10.1016/j.jacc.2011.03.064 10.1093/icvts/ivs098 10.1002/mrm.20110 10.1002/mrm.24878 10.1161/CIRCIMAGING.111.963587 10.3348/kjr.2017.18.1.113 10.1253/circj.CJ-15-1309 10.1136/heartjnl-2012-303052 10.1148/radiol.14141120 10.1159/000478901 10.1016/j.jcmg.2015.11.008 10.1007/s00508-017-1267-y 10.1093/ehjci/jet245 10.1016/j.jacc.2019.11.032 10.1016/S0735-1097(99)00630-0 10.1016/j.ahj.2016.02.010 10.1016/j.acvd.2016.05.010 10.1093/ehjci/jex052 10.1186/1532-429X-14-50 10.1016/j.jcmg.2017.08.025 10.1016/j.cjca.2014.04.026 10.1007/s11936-015-0391-0 10.1007/s10741-017-9621-8 10.1159/000493164 10.3348/kjr.2019.0441 10.1148/ryct.2019190027 10.1186/s12968-017-0329-7 10.1007/s00392-017-1153-7 10.1016/j.jcmg.2018.02.002 10.1186/1532-429X-14-49 10.1186/1532-429X-12-33 10.1016/j.jcmg.2009.03.001 10.1007/s10554-012-0054-0 10.1016/j.jvc.2016.06.004 10.1002/clc.23353 10.1053/euhj.1999.1736 10.1161/01.CIR.100.4.361 10.2214/ajr.178.4.1780953 10.1016/j.jcmg.2015.01.009 10.1093/eurheartj/ehx391 10.1136/heartjnl-2020-317125 10.1016/j.jcct.2018.11.008 10.1016/j.jcct.2015.04.002 10.1016/j.jcmg.2015.12.022 10.1161/CIRCIMAGING.113.001508 10.1016/j.jacc.2019.01.070 10.1016/j.jacc.2010.12.046 10.1161/CIRCULATIONAHA.111.051052 10.1093/eurheartj/eht034
Heart Failure Reviews; Cionca C, Zlibut A et. al.

Jul 19th, 2021 - Aortic valve stenosis has become the most common valvular heart disease on account of aging population and increasing life expectancy. Echocardiography is the primary diagnosis tool for this, but it still has many flaws. Therefore, advanced cardio...

Current status and etiology of valvular heart disease in China: a population-based survey.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276378
BMC Cardiovascular Disorders; Yang Y, Wang Z et. al.

Jul 14th, 2021 - The epidemiology of valvular heart disease (VHD) has changed markedly over the last 50 years worldwide, and the prevalence and features of VHD in China are unknown. The objective of this study was to investigate the current status and etiology of ...

Intervention for Asymptomatic Valvular Heart Disease: Analysis of Recent Data and Impli...
https://doi.org/10.1053/j.jvca.2021.05.054
Journal of Cardiothoracic and Vascular Anesthesia; Cormican DS, McHugh S et. al.

Jul 12th, 2021 - Intervention for Asymptomatic Valvular Heart Disease: Analysis of Recent Data and Implications for the Perioperative Echocardiographer.|2021|Cormican DS,McHugh S,Sypert M,Shoubaki A,Boisen M,|

Senescence and senolytics in cardiovascular disease: Promise and potential pitfalls.
https://doi.org/10.1016/j.mad.2021.111540
Mechanisms of Ageing and Development; Owens WA, Walaszczyk A et. al.

Jul 8th, 2021 - Ageing is the biggest risk factor for impaired cardiovascular health, with cardiovascular disease being the cause of death in 40 % of individuals over 65 years old. Ageing is associated with an increased prevalence of atherosclerosis, coronary art...

see more →

Guidelines  16 results

2020 ACC/AHA guideline for the management of patients with valvular heart disease: A re...
https://doi.org/10.1016/j.jtcvs.2021.04.002
The Journal of Thoracic and Cardiovascular Surgery; , Otto CM et. al.

May 11th, 2021 - 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.|2021| ,Otto CM,Nishimura RA,Bonow RO,Cara...

2019 HRS expert consensus statement on evaluation, risk stratification, and management ...
https://doi.org/10.1016/j.hrthm.2019.05.007
Heart Rhythm; Towbin JA, McKenna WJ et. al.

May 12th, 2019 - Arrhythmogenic cardiomyopathy (ACM) is an arrhythmogenic disorder of the myocardium not secondary to ischemic, hypertensive, or valvular heart disease. ACM incorporates a broad spectrum of genetic, systemic, infectious, and inflammatory disorders....

2019 AATS/ACC/ASE/SCAI/STS Expert Consensus Systems of Care Document: A Proposal to Opt...
https://doi.org/10.1016/j.athoracsur.2019.03.001
The Annals of Thoracic Surgery; Nishimura RA, O'Gara PT et. al.

Apr 23rd, 2019 - 2019 AATS/ACC/ASE/SCAI/STS Expert Consensus Systems of Care Document: A Proposal to Optimize Care for Patients With Valvular Heart Disease: A Joint Report of the American Association for Thoracic Surgery, American College of Cardiology, American S...

2017 ESC/EACTS Guidelines for the management of valvular heart disease.
https://doi.org/10.1093/ejcts/ezx324
European Journal of Cardio-thoracic Surgery : Official Jo... Falk V, Baumgartner H et. al.

Nov 20th, 2017 - 2017 ESC/EACTS Guidelines for the management of valvular heart disease.|2017|Falk V,Baumgartner H,Bax JJ,De Bonis M,Hamm C,|standards,standards,surgery,standards,

Surgery for aortic dilatation in patients with bicuspid aortic valves: A statement of c...
https://doi.org/10.1016/j.jtcvs.2015.12.001
The Journal of Thoracic and Cardiovascular Surgery; , Hiratzka LF et. al.

Mar 20th, 2016 - Two guidelines from the American College of Cardiology (ACC), the American Heart Association (AHA), and collaborating societies address the risk of aortic dissection in patients with bicuspid aortic valves and severe aortic enlargement: The "2010 ...

see more →

Drugs  44 results see all →

Clinicaltrials.gov  39 results

Efficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized mulTi-cEntric Double-blind Phase II Study
https://clinicaltrials.gov/ct2/show/NCT03315832

Mar 17th, 2020 - Aortic stenosis (AS) is the most frequent valvular heart disease in Western countries, with increasing prevalence. Recent guidelines recommend aortic valve intervention (surgical aortic valve replacement [SAVR] or transcatheter aortic valve replac...

Prognosis in Asymptomatic Mitral Regurgitation (PAMIR) Study
https://clinicaltrials.gov/ct2/show/NCT00509080

Feb 26th, 2020 - Background: One of the most difficult issues in the care of asymptomatic patients with severe valvular heart disease, particularly mitral regurgitation, is the timing of the surgical intervention. Unlike the stenotic lesions, regurgitant lesions o...

CPAP Treatment and Postoperative Outcomes in Patients With Rheumatic Valvular Heart Disease
https://clinicaltrials.gov/ct2/show/NCT03398733

Feb 24th, 2020 - Between December 1, 2017 and June 30 2019, 200 patients with chronic heart failure caused by rheumatic valvular heart disease waiting for heart valve replacement in Department of Cardiovascular Surgery were screened for obstructive sleep apnea (OS...

Caisson Transcatheter Mitral Valve Replacement (TMVR)
https://clinicaltrials.gov/ct2/show/NCT03661398

Jan 27th, 2020 - The treatment guidelines for valvular heart disease indicate that surgical correction of primary mitral valve regurgitation (MR) is a Class I recommendation. Recent evidence indicates that valve replacement is at least as effective as repair in bo...

Goal-directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study
https://clinicaltrials.gov/ct2/show/NCT00512759

Nov 20th, 2019 - Background: Heart failure (HF) is a chronic and progressive illness resulting from a variety of cardiac causes, including ischemic and valvular heart disease, dilatative cardiomyopathy or hypertension. HF may also develop suddenly, particularly as...

see more →

News  162 results

LAAOS III Lessons: Surgical Technique and Anticoagulation Key to Cut Stroke in AF
https://www.medscape.com/viewarticle/950970

May 27th, 2021 - This transcript has been edited for clarity. John M. Mandrola, MD: Hi, everyone. This is John Mandrola from theheart.org | Medscape Cardiology. I'm joined today by cardiac surgeon Professor Richard Whitlock, from McMaster University in Hamilton, O...

Lamictal (lamotrigine): Drug Safety Communication - Studies Show Increased Risk of Heart Rhythm Problems in Patients with Heart Disease | FDA
https://www.fda.gov/safety/medical-product-safety-information/lamictal-lamotrigine-drug-safety-communication-studies-show-increased-risk-heart-rhythm-problems

[Posted 03/31/2021]  AUDIENCE: Patient, Health Professional, Pharmacy, Neurology, Cardiology, Psychiatry  ISSUE: An FDA review of study findings showed a potential increased risk of heart rhythm problems, called arrhythmias, in patients with heart...

Valvular Heart Disease Clinical Practice Guidelines (ACC/AHA, 2021)
https://reference.medscape.com/viewarticle/944947

Jan 31st, 2021 - The American College of Cardiology (ACC) and American Heart Association (AHA) released their updated recommendations on managing valvular heart disease in December 2020.[1,2] Ten key messages are outlined below. Top 10 Take-Home Messages Valvular ...

ACC/AHA Valvular Heart Disease Update Backs Less-Invasive Approach
https://www.medscape.com/viewarticle/943526

Jan 3rd, 2021 - The latest iteration of the American College of Cardiology/American Heart Association (ACC/AHA) Guideline for the Management of Patients With Valvular Heart Disease emphasizes a less invasive approach to the management of patients with valvular he...

Bleeding a Major Adverse Event in Extracorporeal Life Support
https://www.medscape.com/viewarticle/940303

Nov 3rd, 2020 - NEW YORK (Reuters Health) - Bleeding is the predominant hemocompatibility-related adverse event (HRAE) in patients with refractory cardiopulmonary failure receiving venoarterial-extracorporeal life support (VA-ECLS), according to a registry analys...

see more →

Patient Education  3 results see all →